Bioinspired negatively charged calcium phosphate nanocarriers for cardiac delivery of MicroRNAs.
Di Mauro V
Nanomedicine (Lond). 2016 Mar 16;11(8):891-906. doi: 10.2217/nnm.16.26
Peptidomimetic Targeting of Cavβ2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function.
Rusconi F
Circulation. 2016 Aug 2;134(7):534-46. doi: 10.1161/CIRCULATIONAHA.116.021347
Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy.
Zaglia T
Proc Natl Acad Sci U S A. 2017 Oct 9;114(43):E9006-E9015. doi: 10.1073/pnas.1708772114
Inhalation of peptide-loaded nanoparticles improves heart failure.
Miragoli M
Sci Transl Med. 10(424)pii: eaan6205. doi: 10.1126/scitranslmed.aan6205
Wnt signalling mediates miR-133a nuclear re-localization for the transcriptional control of Dnmt3b in cardiac cells.
Di Mauro V
Sci Rep. 2019 Jun 27;9(1):9320. doi: 10.1038/s41598-019-45818-4
Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.
Prondzynski M
EMBO Mol Med. 2019 Nov 3;11(12):e11115. doi: 10.15252/emmm.201911115
Novel Basic Science Insights to Improve the Management of Heart Failure: Review of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology.
Ameri P
Int J Mol Sci. 2020 Feb 11;21(4)doi: 10.3390/ijms21041192
The role of mitochondrial dynamics in cardiovascular diseases.
Forte M
Br J Pharmacol. 2020 May 19;178(10):2060-2076. doi: 10.1111/bph.15068
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome.
Di Mauro V
Front Physiol. 2021 Jan 8;11:616819. doi: 10.3389/fphys.2020.616819
Optimization of In Vivo Studies by Combining Planar Dynamic and Tomographic Imaging: Workflow Evaluation on a Superparamagnetic Nanoparticles System.
Rouchota M
Mol Imaging. 2021 Jan 15;2021:6677847. doi: 10.1155/2021/6677847